The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer (EC) in DUO-E: Results by BRCA1/BRCA2 mutation (BRCAm) status.
 
Els Van Nieuwenhuysen
Consulting or Advisory Role - AstraZeneca (Inst); Oncoinvent; Regeneron (Inst)
Research Funding - AstraZeneca (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oncoinvent (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Regeneron (Inst)
 
Jean-Francois Baurain
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Sanofi/Regeneron (Inst); Sun Pharma (Inst); Sun Pharma (Inst)
 
Hye Sook Chon
Honoraria - Curio Science; Envision Communications; Guidepoint Global; MJH Healthcare Holdings, LLC
Consulting or Advisory Role - Eisai; Envision Communications
Speakers' Bureau - Clinical Care Options
Travel, Accommodations, Expenses - Agenus
 
Jessica Thomes Pepin
Consulting or Advisory Role - Seagen
 
Michael J. Sundborg
Employment - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Speakers' Bureau - GlaxoSmithKline
 
Michael A. Gold
Travel, Accommodations, Expenses - ASCCP
 
Byoung-Gie Kim
No Relationships to Disclose
 
Stephanie V. Blank
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Aravive (Inst); AstraZeneca (Inst); F. Hoffmann LaRoche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Ji-Hong Liu
No Relationships to Disclose
 
Michael McCollum
Employment - Virginia Oncology Associates
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Seagen (Inst)
 
Masahiko Mori
No Relationships to Disclose
 
Goda Jonuškienė
Travel, Accommodations, Expenses - AstraZeneca; SERVIER
 
Kathleen N. Moore
Leadership - GOG Partners; NRG Oncology (Inst)
Honoraria - Great Debates and Updates; Physicans' Education Resource; Prime Oncology; Research To Practice
Consulting or Advisory Role - AADi; aadi; Alkermes (Inst); AstraZeneca; Blueprint Medicines (Inst); Caris Life Sciences; Clovis Oncology; Duality Biologics (Inst); Eisai; Genentech/Roche; GlaxoSmithKline/Tesaro (Inst); Hengrui Pharmaceutical; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Merck; Mereo BioPharma; Mersana (Inst); Myriad Genetics; Novartis; Novartis/Pfizer; Onconova Therapeutics; OncXerna Therapeutics; Regeneron; VBL Therapeutics; Verastem/Pharmacyclics; zentalis
Research Funding - Agenus (Inst); Amgen (Inst); artios (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); cyteir (Inst); Daiichi Sankyo/Lilly (Inst); Genentech (Inst); Immunocore (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline
Other Relationship - GOG Partners (Inst)
 
Zoltán Novák
Honoraria - AstraZeneca; Richter Gedeon; Sofmedica
Speakers' Bureau - MSD Oncology; Richter Gedeon
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Pedro Ramos
No Relationships to Disclose
 
Charles Andreé Joseph de Padua
No Relationships to Disclose
 
Marta Gil-Martin
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - GlaxoSmithKline; MSD Oncology
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Matthew Kowgier
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Paula Michelle del Rosario
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Shannon Neville Westin
Consulting or Advisory Role - AstraZeneca; BioAscent; Caris Life Sciences; Clovis Oncology; Curio Science; Eisai; EQRX; Genentech; Gerson Lehrman Group; Gilead Sciences; GlaxoSmithKline; Immunocore; Immunogen; Lilly; Medscape; Merck; Mereo BioPharma; Mersana; Mersana; NGM Biopharmaceuticals; Nuvectis Pharma; Nuvectis Pharma; OncLive; pharma&; Roche; Seagen; Targeted Oncology; Vaniam Group; Verastem; Vincerx Pharma; Zentalis; ZielBio
Research Funding - AstraZeneca (Inst); Avenge Bio (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Jazz Pharmaceuticals (Inst); Mereo BioPharma (Inst); Novartis (Inst); Nuvectis Pharma (Inst); Roche/Genentech (Inst); Zentalis (Inst)